A

Asia Vets Holdings Ltd
SGX:5RE

Watchlist Manager
Asia Vets Holdings Ltd
SGX:5RE
Watchlist
Price: 0.047 SGD Market Closed
Market Cap: 6.9m SGD
Have any thoughts about
Asia Vets Holdings Ltd?
Write Note
5RE
/
Income Statement
/
Revenue

Asia Vets Holdings Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Asia Vets Holdings Ltd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
A
Asia Vets Holdings Ltd
SGX:5RE
Revenue
S$2.6m
CAGR 3-Years
-14%
CAGR 5-Years
-5%
CAGR 10-Years
-23%
Raffles Medical Group Ltd
SGX:BSL
Revenue
S$701.8m
CAGR 3-Years
2%
CAGR 5-Years
7%
CAGR 10-Years
7%
I
ISEC Healthcare Ltd
SGX:40T
Revenue
S$71.9m
CAGR 3-Years
24%
CAGR 5-Years
11%
CAGR 10-Years
17%
O
Oue Lippo Healthcare Ltd
SGX:5WA
Revenue
S$155.5m
CAGR 3-Years
99%
CAGR 5-Years
52%
CAGR 10-Years
15%
Thomson Medical Group Ltd
SGX:A50
Revenue
S$351.2m
CAGR 3-Years
13%
CAGR 5-Years
5%
CAGR 10-Years
18%
No Stocks Found

Asia Vets Holdings Ltd
Glance View

Market Cap
6.9m SGD
Industry
Health Care

Asia Vets Holdings Ltd. is an investment company, which engages in the provision of veterinary services, and sale of veterinary medicines and products. Ltd., engaged in providing veterinary care and clinical services to small animals in Singapore. The firm operates two veterinary clinics, which provide a full range of general veterinary services, including medical, surgical and dental care for small animals including dogs, cats, rabbits and other pocket pets. The firm is providing its patients with advanced diagnostic and the latest in surgical procedures, such as key-hole surgery. The company also offers complementary remedies and treatments such as acupuncture and traditional Chinese medicine at its clinics. In addition to surgical oncology and chemotherapy, the Company also utilizes natural killer cell and stem cell therapies in the treatment of cancers. The firm provides a range of services, including allergy testing and treatment, day hospitalization, dental services, diagnostic imaging, pocket pets and soft tissue surgery and routine sterilization.

5RE Intrinsic Value
0.046 SGD
Overvaluation 1%
Intrinsic Value
Price
A
What is Intrinsic Value?

See Also

What is Asia Vets Holdings Ltd's Revenue?
Revenue
2.6m SGD

Based on the financial report for Jun 30, 2024, Asia Vets Holdings Ltd's Revenue amounts to 2.6m SGD.

What is Asia Vets Holdings Ltd's Revenue growth rate?
Revenue CAGR 10Y
-23%

Over the last year, the Revenue growth was 11%. The average annual Revenue growth rates for Asia Vets Holdings Ltd have been -14% over the past three years , -5% over the past five years , and -23% over the past ten years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 211,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.